Postpartum Deworming: Improving Breastfeeding and Optimizing Infant Growth
Status:
Completed
Trial end date:
2016-09-16
Target enrollment:
Participant gender:
Summary
Women of reproductive age are considered a high-risk group for worm infections by the World
Health Organization. Maternal infection and anemia contribute to infant malnutrition by
affecting milk quality and quantity, and duration of exclusive breastfeeding. To date, no
study has investigated the health benefits of postpartum deworming to infants or mothers. A
randomized controlled trial will be conducted in Peru to investigate the effectiveness of
integrating deworming into routine postpartum care. The primary measure of effect will be
infant weight gain between birth and six months of age. Other infant and maternal health
indicators will also be ascertained.
Phase:
Phase 4
Details
Lead Sponsor:
McGill University Health Center McGill University Health Centre/Research Institute of the McGill University Health Centre